High medication prices can create a financial burden for patients and reduce medication initiation. To improve decision making, public policy is supporting development of tools to provide real-time prescription drug prices. We reviewed the literature on medication cost conversations to characterize the context in which these tools may be used. Our review included 42 articles: a median of 84% of patients across four clinical specialties reported a desire for cost conversations (n = 7 articles) but only 23% reported having held a cost conversation across six specialties (n = 16 articles). Non-White and older patients were less likely to report having held a cost conversation than White and younger patients in 9 of 13 and 5 of 9 articles, respectively, examining these associations. Our review indicates that tools providing price information may not result in improved decision making without complementary interventions that increase the frequency of cost conversations with a focus on protected groups.
AlexanderG. C.CasalinoL. P.MeltzerD. O. (2003). Patient-physician communication about out-of-pocket costs. Journal of the American Medical Association, 290(7), 953–958. https://doi.org/10.1001/jama.290.7.953
2.
AlexanderG. C.CasalinoL. P.MeltzerD. O. (2005). Physician strategies to reduce patients’ out-of-pocket prescription costs. Archives of Internal Medicine, 165(6), 633–636. https://doi.org/10.1001/archinte.165.6.633
3.
AlexanderG. C.CasalinoL. P.TsengC. W.McFaddenD.MeltzerD. O. (2004). Barriers to patient-physician communication about out-of-pocket costs. Journal of General Internal Medicine, 19(8), 856–860. https://doi.org/10.1111/j.1525-1497.2004.30249.x
4.
BeardA. J.SleathB.BlalockS. J.RothM.WeinbergerM.TudorG.ChewningB. (2010). Predictors of rheumatoid arthritis patient-physician communication about medication costs during visits to rheumatologists. Arthritis Care & Research (Hoboken), 62(5), 632–639. https://doi.org/10.1002/acr.20083
5.
BeranM. S.LaouriM.SuttorpM.BrookR. (2007). Medication costs: The role physicians play with their senior patients. Journal of the American Geriatrics Society, 55(1), 102–107. https://doi.org/10.1111/j.1532-5415.2006.01011.x
6.
BerryS. R.BellC. M.UbelP. A.EvansW. K.NadlerE.StrevelE. L.NeumannP. J. (2010). Continental divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. Journal of Clinical Oncology, 28(27), 4149–4153. https://doi.org/10.1200/JCO.2010.29.1625
7.
BestvinaC. M.ZulligL. L.RushingC.ChinoF.SamsaG. P.AltomareI.TulskyJ.UbelP.SchragD.NicollaJ.AbernethyA. P.PeppercornJ.ZafarS. Y. (2014). Patient-oncologist cost communication, financial distress, and medication adherence. Journal of Oncology Practice, 10(3), 162–167. https://doi.org/10.1200/JOP.2014.001406
8.
Binder-FinnemaP.DzurillaK.HsiaoB.FraenkelL. (2019). Qualitative exploration of triangulated, shared decision-making in rheumatoid arthritis. Arthritis Care & Research, 71(12), 1576–1582.
9.
Bonakdar TehraniA.CunninghamP. J. (2017). Closing the Medicare doughnut hole: Changes in prescription drug utilization and out-of-pocket spending among Medicare beneficiaries with part D coverage after the Affordable Care Act. Medicare, 55(1), 43–49. https://doi.org/10.1097/MLR.0000000000000613
10.
BriesacherB. A.GurwitzJ. H.SoumeraiS. B. (2007). Patients at-risk for cost-related medication nonadherence: A review of the literature. Journal of General Internal Medicine, 22(6), 864–871.
11.
BrownG. D.HunterW. G.HessonA.DavisJ. K.KirbyC.BarnettJ. A.ByelmacD.UbelP. A. (2017). Discussing out-of-pocket expenses during clinical appointments: An observational study of patient-psychiatrist interactions. Psychiatric Services, 68(6), 610–617. https://doi.org/10.1176/appi.ps.201600275
12.
CarrollJ. K.FarahS.FortunaR. J.LaniganA. M.SandersM.VenciJ. V.FiscellaK. (2019). Addressing medication costs during primary care visits: A before–after study of team-based training. Annals of Internal Medicine, 170(9_Supplement), S46–S53.
13.
ClarkeL. H.BennettE. V.KorotchenkoA. (2014). Negotiating vulnerabilities: How older adults with multiple chronic conditions interact with physicians. Canadian Journal on Aging / La Revue Canadienne Du Vieillissement, 33(1), 26–37. https://doi.org/10.1017/S0714980813000597
DoshiJ. A.LiP.HuoH.PettitA. R.ArmstrongK. A. (2018). Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents. Journal of Clinical Oncology, 36(5), 476–482.
18.
DusetzinaS. B.WinnA. N.AbelG. A.HuskampH. A.KeatingN. L. (2014). Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. Journal of Clinical Oncology, 32(4), 306–311. https://doi.org/10.1200/jco.2013.52.9123
19.
EkdahlA. W.HellströmI.AnderssonL.FriedrichsenM. (2012). Too complex and time-consuming to fit in! Physicians’ experiences of elderly patients and their participation in medical decision making: A grounded theory study. BMJ Open, 2(3), e001063. https://doi.org/10.1136/bmjopen-2012-001063
20.
ErathA.DusetzinaS. B. (2020). Assessment of expected out-of-pocket spending for rheumatoid arthritis biologics among patients enrolled in Medicare part D, 2010-2019. JAMA Network Open, 3(4), e203969. https://doi.org/10.1001/jamanetworkopen.2020.3969
21.
EversonJ.FrisseM. E.DusetzinaS. B. (2019). Real-time benefit tools for drug prices. Journal of the American Medical Association, 322(24), 2383–2384.
22.
FraeymanJ.SymonsL.De LoofH.De MeyerG. R.RemmenR.BeutelsP.Van HalG. (2015). Medicine price awareness in chronic patients in Belgium. Health Policy, 119(2), 217–223. https://doi.org/10.1016/j.healthpol.2014.12.004
23.
GaneshA.King-ShierK.MannsB. J.HillM. D.CampbellD. J. (2017). Money is brain: Financial barriers and consequences for Canadian stroke patients. Canadian Journal of Neurological Sciences, 44(2), 146–151. https://doi.org/10.1017/cjn.2016.411
24.
GoldR.CottrellE.BunceA.MiddendorfM.HollombeC.CowburnS.MahrP.MelgarG. (2017). Developing Electronic Health Record (EHR) strategies related to health center patients’ social determinants of health. Journal of the American Board of Family Medicine, 30(4), 428–447. https://doi.org/10.3122/jabfm.2017.04.170046
25.
HamelL. M.DoughertyD. W.HastertT. A.SeymourE. K.KimS.AssadH.PhaloreJ.EgglyS. (2020). The DISCO app: A pilot test of an electronic patient intervention to reduce the financial burden of cancer through improved cost communication. Journal of Clinical Oncology, 38(15_Suppl), e24197. https://doi.org/10.1200/JCO.2020.38.15_suppl.e24197
26.
HamelL. M.DoughertyD. W.KimS.HeathE. I.MabundaL.TadesseE.HillR.EgglyS. (2021). DISCO App: Study protocol for a randomized controlled trial to test the effectiveness of a patient intervention to reduce the financial burden of cancer in a diverse patient population. Trials, 22(1), 636. https://doi.org/10.1186/s13063-021-05593-y
27.
HarringtonN. G.ScottA. M.SpencerE. A. (2020). Working toward evidence-based guidelines for cost-of-care conversations between patients and physicians: A systematic review of the literature. Social Science & Medicine, 258, 113084. https://doi.org/10.1016/j.socscimed.2020.113084
28.
HeislerM.WagnerT. H.PietteJ. D. (2004). Clinician identification of chronically ill patients who have problems paying for prescription medications. American Journal of Medicine, 116(11), 753–758. https://doi.org/10.1016/j.amjmed.2004.01.013
29.
HenriksonN. B.TuzzioL.LoggersE. T.MiyoshiJ.BuistD. S. (2014). Patient and oncologist discussions about cancer care costs. Support Care Cancer, 22(4), 961–967. https://doi.org/10.1007/s00520-013-2050-x
30.
HerkertD.VijayakumarP.LuoJ.SchwartzJ. I.RabinT. L.DeFilippoE.LipskaK. J. (2019). Cost-related insulin underuse among patients with diabetes. JAMA Internal Medicine, 179(1), 112–114. https://doi.org/10.1001/jamainternmed.2018.5008
31.
IrwinB.KimmickG.AltomareI.MarcomP. K.HouckK.ZafarS. Y.PeppercornJ. (2014). Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist, 19(11), 1135–1140. https://doi.org/10.1634/theoncologist.2014-0117
32.
KesselheimA. S.AvornJ.SarpatwariA. (2016). The high cost of prescription drugs in the United States: Origins and prospects for reform. Journal of the American Medical Association, 316(8), 858–871.
33.
KhanS.SylvesterR.ScottD.PittsB. (2008). Physicians’ opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states. Journal of Managed Care Pharmacy, 14(8), 780–789. https://doi.org/10.18553/jmcp.2008.14.8.780
34.
MummadiS. R.MishraR. (2018). Effectiveness of provider price display in computerized physician order entry (CPOE) on healthcare quality: A systematic review. Journal of the American Medical Informatics Association, 25(9), 1228–1239.
35.
ParkY. J.MartinE. G. (2017). Medicare part D’s effects on drug utilization and out-of-pocket costs: A systematic review. Health Services Research, 52(5), 1685–1728. https://doi.org/10.1111/1475-6773.12534
36.
PatelM. R.CoffmanJ. M.TsengC. W.ClarkN. M.CabanaM. D. (2009). Physician communication regarding cost when prescribing asthma medication to children. Clinical Pediatrics (Phila), 48(5), 493–498. https://doi.org/10.1177/0009922808330110
37.
PatelM. R.JagsiR.ResnicowK.SmithS. N.HamelL. M.SuC.GriggsJ. J.BuchananD.IsaacsonN.TorbyM. (2021). A scoping review of behavioral interventions addressing medical financial hardship. Population Health Management, 24(6), 710–721.
38.
PatelM. R.ResnicowK.LangI.KrausK.HeislerM. (2018). Solutions to address diabetes-related financial burden and cost-related nonadherence: Results from a pilot study. Health Education & Behavior, 45(1), 101–111. https://doi.org/10.1177/1090198117704683
39.
PatelM. R.ShahK. S.ShallcrossM. L. (2015). A qualitative study of physician perspectives of cost-related communication and patients’ financial burden with managing chronic disease. BMC Health Services Research, 15(1), 1–7.
40.
PatelM. R.WheelerJ. R. (2014). Physician-patient communication on cost and affordability in asthma care. Who wants to talk about it and who is actually doing it. Annals of the American Thoracic Society, 11(10), 1538–1544. https://doi.org/10.1513/AnnalsATS.201408-363OC
41.
PeckB. M. (2011). Age-related differences in doctor-patient interaction and patient satisfaction. Current Gerontology and Geriatrics Research, 2011, 137492. https://doi.org/10.1155/2011/137492
42.
PerezS. L.WeissmanA.ReadS.SmithC. D.ColelloL.PeterD.NickelW. (2019). U.S. internists’ perspectives on discussing cost of care with patients: Structured interviews and a survey. Annals of Internal Medicine, 170(9_Suppl), S39–S45. https://doi.org/10.7326/M18-2136
43.
Perez JollesM.RichmondJ.ThomasK. C. (2019). Minority patient preferences, barriers, and facilitators for shared decision-making with health care providers in the USA: A systematic review. Patient Education and Counseling, 102(7), 1251–1262. https://doi.org/10.1016/j.pec.2019.02.003
44.
PietteJ. D.HeislerM.WagnerT. H. (2004). Cost-related medication underuse: Do patients with chronic illnesses tell their doctors?Archives of Internal Medicine, 164(16), 1749–1755. https://doi.org/10.1001/archinte.164.16.1749
45.
RaiA.ZhengZ.ZhaoJ.de MoorJ. S.EkwuemeD. U.YabroffK. R. (2020). Patient-provider discussions about out-of-pocket costs of cancer care in the U.S. American Journal of Preventive Medicine, 59(2), 228–236. https://doi.org/10.1016/j.amepre.2020.02.017
46.
RyanM. S.SoodN. (2019). Analysis of state-level drug pricing transparency laws in the United States. JAMA Network Open, 2(9), e1912104.
47.
SchmittdielJ. A.SteersN.DuruO. K.EttnerS. L.BrownA. F.FungV.HsuJ.QuiterE.TsengC. W.MangioneC. M. (2010). Patient-provider communication regarding drug costs in Medicare part D beneficiaries with diabetes: A TRIAD Study. BMC Health Services Research, 10, 164. https://doi.org/10.1186/1472-6963-10-164
48.
SchragD.HangerM. (2007). Medical oncologists’ views on communicating with patients about chemotherapy costs: A pilot survey. Journal of Clinical Oncology, 25(2), 233–237. https://doi.org/10.1200/jco.2006.09.2437
49.
ShihY. T.ChienC. R. (2017). A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment. Cancer, 123(6), 928–939. https://doi.org/10.1002/cncr.30423
50.
ShrankW. H.FoxS. A.KirkA.EttnerS. L.CantrellC. H.GlassmanP.AschS. M. (2006). The effect of pharmacy benefit design on patient-physician communication about costs. Journal of General Internal Medicine, 21(4), 334–339. https://doi.org/10.1111/j.1525-1497.2006.00402.x
51.
SlotaC.DavisS. A.BlalockS. J.CarpenterD. M.MuirK. W.RobinA. L.SleathB. (2017). Patient-physician communication on medication cost during Glaucoma visits. Optometry and Vision Science, 94(12), 1095–1101. https://doi.org/10.1097/OPX.0000000000001139
52.
SteenA. J.MannJ. A.CarlbergV. M.KimballA. B.MustyM. J.SimpsonE. L. (2017). Understanding the cost of dermatologic care: A survey study of dermatology providers, residents, and patients. Journal of the American Academy of Dermatology, 76(4), 609–617. https://doi.org/10.1016/j.jaad.2016.11.049
53.
TarnD. M.PaternitiD. A.HeritageJ.HaysR. D.KravitzR. L.WengerN. S. (2006). Physician communication about the cost and acquisition of newly prescribed medications. American Journal of Managed Care, 12(11), 657–664. https://www.ncbi.nlm.nih.gov/pubmed/17090222
54.
ThomsonJ.SchofieldP.MileshkinL.AgalianosE.SavulescuJ.ZalcbergJ.JeffordM. (2006). Do oncologists discuss expensive anti-cancer drugs with their patients?Annals of Oncology, 17(4), 702–708. https://doi.org/10.1093/annonc/mdj136
55.
TsengC. W.DudleyR. A.BrookR. H.KeelerE.HixonA. L.ManlucuL. R.MangioneC. M. (2009). Elderly patients’ knowledge of drug benefit caps and communication with providers about exceeding caps. Journal of the American Geriatrics Society, 57(5), 848–854. https://doi.org/10.1111/j.1532-5415.2009.02244.x
56.
TsengC. W.DudleyR. A.BrookR. H.KeelerE.SteersW. N.AlexanderG. C.WaitzfelderB. E.MangioneC. M. (2007). Elderly patients’ preferences and experiences with providers in managing their drug costs. Journal of the American Geriatrics Society, 55(12), 1974–1980. https://doi.org/10.1111/j.1532-5415.2007.01445.x
57.
TsengC. W.WaitzfelderB. E.TierneyE. F.GerzoffR. B.MarreroD. G.PietteJ. D.KarterA. J.CurbJ. D.ChungR.MangioneC. M.CrossonJ. C.DudleyR. A. (2010). Patients’ willingness to discuss trade-offs to lower their out-of-pocket drug costs. Archives of Internal Medicine, 170(16), 1502–1504. https://doi.org/10.1001/archinternmed.2010.287
58.
UbelP. A.ZhangC. J.HessonA.DavisJ. K.KirbyC.BarnettJ.HunterW. G. (2016). Study of physician and patient communication identifies missed opportunities to help reduce patients’ out-of-pocket spending. Health Affairs, 35(4), 654–661.
59.
VictoorA.NoordmanJ.PotappelA.MeijersM.KloekC. J. J.de JongJ. D. (2019). Discussing patients’ insurance and out-of-pocket expenses during GPs’ consultations. BMC Health Services Research, 19(1), 141. https://doi.org/10.1186/s12913-019-3966-8
60.
WilsonI. B.SchoenC.NeumanP.StrolloM. K.RogersW. H.ChangH.SafranD. G. (2007). Physician-patient communication about prescription medication nonadherence: A 50-state study of America’s seniors. Journal of General Internal Medicine, 22(1), 6–12. https://doi.org/10.1007/s11606-006-0093-0
61.
WoodwardE. N.MatthieuM. M.UchenduU. S.RogalS.KirchnerJ. E. (2019). The health equity implementation framework: Proposal and preliminary study of hepatitis C virus treatment. Implementation Science, 14(1), 1–18.
62.
ZafarS. Y.ChinoF.UbelP. A.RushingC.SamsaG.AltomareI.NicollaJ.SchragD.TulskyJ. A.AbernethyA. P.PeppercornJ. M. (2015). The utility of cost discussions between patients with cancer and oncologists. American Journal of Managed Care, 21(9), 607–615. https://www.ncbi.nlm.nih.gov/pubmed/26618364
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
